These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 27213455)

  • 1. The Roles of NDR Protein Kinases in Hippo Signalling.
    Hergovich A
    Genes (Basel); 2016 May; 7(5):. PubMed ID: 27213455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation and functions of mammalian LATS/NDR kinases: looking beyond canonical Hippo signalling.
    Hergovich A
    Cell Biosci; 2013 Aug; 3(1):32. PubMed ID: 23985307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NDR/LATS protein kinases in immunology and cancer biology.
    Sharif AAD; Hergovich A
    Semin Cancer Biol; 2018 Feb; 48():104-114. PubMed ID: 28579171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downstream of human NDR kinases: impacting on c-myc and p21 protein stability to control cell cycle progression.
    Cornils H; Kohler RS; Hergovich A; Hemmings BA
    Cell Cycle; 2011 Jun; 10(12):1897-904. PubMed ID: 21593588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinases of the Hippo pathway: regulation and substrates.
    Avruch J; Zhou D; Fitamant J; Bardeesy N; Mou F; Barrufet LR
    Semin Cell Dev Biol; 2012 Sep; 23(7):770-84. PubMed ID: 22898666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring the Kinase Activities of the LATS/NDR Protein Kinases.
    Hergovich A
    Methods Mol Biol; 2019; 1893():305-317. PubMed ID: 30565143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The NDR/LATS protein kinases in neurobiology: Key regulators of cell proliferation, differentiation and migration in the ocular and central nervous system.
    Santos PF; Fazendeiro B; Luca FC; Ambrósio AF; Léger H
    Eur J Cell Biol; 2023 Jun; 102(2):151333. PubMed ID: 37327741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hippo Signaling in Mitosis: An Updated View in Light of the MEN Pathway.
    Hergovich A
    Methods Mol Biol; 2017; 1505():265-277. PubMed ID: 27826870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mob Family Proteins: Regulatory Partners in Hippo and Hippo-Like Intracellular Signaling Pathways.
    Duhart JC; Raftery LA
    Front Cell Dev Biol; 2020; 8():161. PubMed ID: 32266255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Furry protein suppresses nuclear localization of yes-associated protein (YAP) by activating NDR kinase and binding to YAP.
    Irie K; Nagai T; Mizuno K
    J Biol Chem; 2020 Mar; 295(10):3017-3028. PubMed ID: 31996378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Hippo pathway in disease and therapy: cancer and beyond.
    Gomez M; Gomez V; Hergovich A
    Clin Transl Med; 2014; 3():22. PubMed ID: 25097725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway.
    Meng Z; Moroishi T; Mottier-Pavie V; Plouffe SW; Hansen CG; Hong AW; Park HW; Mo JS; Lu W; Lu S; Flores F; Yu FX; Halder G; Guan KL
    Nat Commun; 2015 Oct; 6():8357. PubMed ID: 26437443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hippo pathway - brief overview of its relevance in cancer.
    Zygulska AL; Krzemieniecki K; Pierzchalski P
    J Physiol Pharmacol; 2017 Jun; 68(3):311-335. PubMed ID: 28820389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monopolar spindle-one-binder protein 2 regulates the activity of large tumor suppressor/yes-associated protein to inhibit the motility of SMMC-7721 hepatocellular carcinoma cells.
    Zhang W; Shen J; Gu F; Zhang Y; Wu W; Weng J; Liao Y; Deng Z; Yuan Q; Zheng L; Zhang Y; Shen W
    Oncol Lett; 2018 Apr; 15(4):5375-5383. PubMed ID: 29552181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammalian NDR/LATS protein kinases in hippo tumor suppressor signaling.
    Hergovich A; Hemmings BA
    Biofactors; 2009; 35(4):338-45. PubMed ID: 19484742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Hippo Pathway: Biology and Pathophysiology.
    Ma S; Meng Z; Chen R; Guan KL
    Annu Rev Biochem; 2019 Jun; 88():577-604. PubMed ID: 30566373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The characterisation of LATS2 kinase regulation in Hippo-YAP signalling.
    Hoa L; Kulaberoglu Y; Gundogdu R; Cook D; Mavis M; Gomez M; Gomez V; Hergovich A
    Cell Signal; 2016 May; 28(5):488-497. PubMed ID: 26898830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MOB1 Mediated Phospho-recognition in the Core Mammalian Hippo Pathway.
    Couzens AL; Xiong S; Knight JDR; Mao DY; Guettler S; Picaud S; Kurinov I; Filippakopoulos P; Sicheri F; Gingras AC
    Mol Cell Proteomics; 2017 Jun; 16(6):1098-1110. PubMed ID: 28373298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stable MOB1 interaction with Hippo/MST is not essential for development and tissue growth control.
    Kulaberoglu Y; Lin K; Holder M; Gai Z; Gomez M; Assefa Shifa B; Mavis M; Hoa L; Sharif AAD; Lujan C; Smith ESJ; Bjedov I; Tapon N; Wu G; Hergovich A
    Nat Commun; 2017 Sep; 8(1):695. PubMed ID: 28947795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of mammalian sterile 20-like kinase 2-dependent phosphorylations of Mps one binder 1B in the activation of nuclear Dbf2-related kinases.
    Bao Y; Sumita K; Kudo T; Withanage K; Nakagawa K; Ikeda M; Ohno K; Wang Y; Hata Y
    Genes Cells; 2009 Dec; 14(12):1369-81. PubMed ID: 19919647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.